The sphygmomanometer is an essential piece of diagnostic equipment, used in many routine consultations in primary care. Its accuracy depends on correct maintenance and calibration. This study was designed to: (1) assess the maintenance and calibration of sphygmomanometers in use in primary care; (2) assess the clinical, ethical, legal and public health implications of our findings. Method: A researcher assessed the accuracy of mercury and aneroid sphygmomanometers in use in 231 English general practices. He also made enquires about arrangements for the maintenance and calibration of sphygmomanometers. We conducted a small telephone survey in general practices across the country to determine maintenance and calibration arrangements across the country. We carried out a modelling exercise to explore the clinical, ethical and public health implications of our findings.
Introduction
Accurate estimation of blood pressure requires the use of an accurate sphygmomanometer, which has been serviced and calibrated. A British Standard (BS2743) exists for the assessment of sphygmomanometers and this has been endorsed by the British Hypertension Society. 1 Previous surveys have found that sphygmomanometers used in primary care are rarely if ever recalibrated. Hussain found that 23% of practitioners had never (Ͼ6 years) had their sphygmomanometers calibrated. 2 Maskrey et al 3 in North Yorkshire in 1997 found that 40% of practices could not recall when sphygmomanometers were last tested. In twothirds of practices, no testing had taken place for at least a year. 3 They comment that these low levels 4 Nor are these findings confined to Britain. A survey of 125 sphygmomanometers used in a prehospital setting in the USA, found over one-third were more than 4 mm Hg inaccurate and one in 10 more than 8 mm Hg inaccurate. 5 In a separate survey of sphygmomanometers owned by members of the public, one in 10 were more than 6 mm Hg inaccurate. 6 To investigate this problem we conducted a survey of sphygmomanometers used in general practices in Birmingham Health Authority. We tested the accuracy of sphygmomanometers and asked primary care teams about arrangements for their calibration and maintenance. We also conducted a small survey of practices in England and Wales to test the generalisability of our findings. Finally we modelled the implications of the findings for clinical practice. We report our results and discuss their wider implications.
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Subjects and methods
Survey of general practices
Between March and July 1999 a researcher trained in the calibration of sphygmomanometers visited all of the 231 practices serving Birmingham Health Authority. He offered a free assessment of the accuracy of all aneroid and mercury sphygmomanometers in use by any member of the practice, using methods which complied with British Standard (BS2743). 7 A sphygmomanometer, which was tested and certified according to British Standard (BS2743), was obtained from a manufacturer. The rubber air tubing of this sphygmomanometer and a the sphygmomanometer being tested were connected with a Y connector. The air pressure of the combined system was increased to 250 mm Hg. Pressure was then slowly reduced to 20 mm Hg. Any difference in pressure between the certified and tested sphygmomanometers was noted. The measurement error was recorded for each sphygmomanometer. As part of the protocol, enquiries were also made using a checklist, about arrangements for the calibration and maintenance of sphygmomanometers.
Telephone survey
To establish whether similar findings with respect to arrangements for calibration and maintenance applied to the rest of England and Wales, we carried out a small telephone survey. We obtained a list of randomly ordered practice telephone numbers, contacted practices in this order, aiming to obtain results from 50. We secured results from 54 practices. In each we spoke with either a doctor, practice manager or nurse and asked what arrangements were in place to ensure that sphygmomanometers were regularly serviced and calibrated.
Modelling exercise
British Hypertension Society guidelines classify as hypertensive all patients whose systolic blood pressure exceeds 160 mm Hg or diastolic blood pressure exceeds 100 mm Hg. 8 To determine the clinical implications of the findings of our survey, we performed a modelling exercise based on the population of England and Wales. We obtained the distribution of systolic and diastolic blood pressures in the population from the Health Survey of England 1996.
9 This survey provides the most recent estimate of the prevalence of raised blood pressure in the community. For each age-sex group we calculated the prevalence of systolic and diastolic blood pressures exceeding the British Hypertension Society criteria for hypertension. These are the true (gold standard) age-sex specific prevalences of high blood pressure. We then calculated the number of persons who would meet the British Hypertension Society criteria for hypertension if uncalibrated sphygmomanometers-such as those identified in our survey-were used. For each age-sex group we calculated the probability of a normotensive being misclassified as hypertensive. We also calculated the positive predictive values of blood pressure which is measured as hypertensive.
Results
Survey of general practices
A total of 217 (94%) practices-serving a combined population of 1 million-accepted the offer of calibration. In all, 1582 sphygmomanometers were identified: 120 electronic, 949 mercury and 513 aneroid. We were unable to assess the calibration of electronic sphygmomanometers. The calibration errors of the 1462 mercury and aneroid sphygmomanometers are shown in Table 1 . Nineteen percent gave readings which were inaccurate by more than 2 mm Hg; 9.2% gave readings which were inaccurate by more than 5 mm Hg. No practice had arrangements for the ongoing recalibration and maintenance of sphygmomanometers. Nearly 100 sphygmomanometers were in such a poor physical state, for instance they had air leaks or dirt in the mercury, that the tester suggested they be withdrawn from service. There was no relationship between the age and accuracy of sphygmomanometers, with some new devices giving inaccurate readings.
Telephone survey
Of 54 practices contacted in the telephone survey, only one (95% confidence interval (CI) 0.1 to 11.2%) had a formal arrangement for servicing and calibration. Thirty-four practices (95% CI 49% to 75%) accepted servicing and calibration by drug company representatives on an ad-hoc or regular basis. Nineteen practices (95% CI, 23% to 49%) had not serviced or calibrated their sphygmomanometers for years, nor had a servicing or calibration arrangement ever been in place.
Modelling exercise
The results of the modelling exercise are shown in Table 2 . If blood pressure is checked with an uncalibrated sphygmomanometer, a small number of patients will be misclassified. In patients over 35, this is not of great practical significance as the probability of being misclassified is small in relation to the true prevalence of hypertension. However, true hypertension is very infrequent under the age of 35 and is practically never encountered in young women. A woman under 35 whose blood pressure is measured with an uncalibrated sphygmomanometer has a small probability of being misclassified as hypertensive. The positive predictive value of a blood pressure measured as Ͼ160/100 mm Hg is 0% in such a woman. Our model therefore suggests that all young women classified as hypertensive have been misclassified. In men under 25, the positive predictive value of a diastolic blood pressure measured as Ͼ100 mm Hg is 0% and 83.6% for systolic hypertension. Our model suggests that one in every six men under 25 classified as hypertensive has been misclassified.
Discussion
Blood pressure readings taken on any individual vary from minute to minute, hour to hour and day Journal of Human Hypertension to day. There are two causes of this variation: biological variation in blood pressure and measurement error. More than 30 potential sources of measurement error have been cited. 10 Most are easily categorised as either relating to the patient (for example, 'white coat' reaction to the physician, anxiety, pain, full bladder); the clinician (faulty blood pressure measurement technique); or the instrument (sphygmomanometer error). Hypertension is diagnosed after blood pressure measurements taken on three separate occasions. This three-reading policy reduces the probability of making an erroneous diagnosis of hypertension due to biological variation in blood pressure. It may also reduce errors due to patient factors. However, if a patient's blood pressure is measured with a sphygmomanometer which has a systematic error, the blood pressure reading will be inaccurate whether it is repeated three or 300 times. Uncalibrated sphygmomanometer error is therefore of great clinical importance. Since few practices have a system which ensures that sphygmomanometers are accurate, it appears all patients are at risk of this kind of measurement error.
The conclusions of our modelling exercise depend on two facts: that the prevalence of hypertension in young women is very low; and that only young women whose blood pressures exceed 160 mm Hg will be considered for treatment.
Our estimate of the prevalence of hypertension is derived from the Health Survey for England. This was conducted on a representative sample of the population, with blood pressure estimated on the basis of the mean of the second and third of three measures taken on the same occasion.
9 Guidelines recommend clinicians estimate blood pressure on the basis of repeated measures on separate occasions. 8 The reported prevalence of hypertension is lower in surveys where measurement takes place at two or more points in time. 11 The Health Survey for England may therefore have overestimated the true prevalence of hypertension. A recently published survey identified 0.2% of female university students as hypertensive and a declining prevalence of hypertension in successive cohorts. 12 This confirms the impression that hypertension is very uncommon in women of this age.
Might young women who have additional risk factors but with blood pressure below the threshold of 160 mm Hg also benefit from treatment? There is no plausible combination of risk factors which would justify treatment of a young woman for hypertension. According to the Framingham risk equation, a diabetic woman smoker aged 34 with a systolic blood pressure of 159 mm Hg and a total cholesterol to high-density lipoprotein cholesterol of 6.0 has a 5-year cardiovascular risk of 11%. 13 She is therefore below the 15% 5-year risk threshold at which the British Hypertension Society suggests treatment should be offered. 8 One per cent of all women under 35 have systolic blood pressures 150 to 159 mm Hg, 9 less than 0.1% have a total cholesterol to highdensity lipoprotein cholesterol of 6.0; only a tiny minority are diabetic smokers.
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Practical implications of instrument calibration
Calibrating instruments is not difficult or expensive. The police recalibrate radar guns daily, chefs calibrate thermometers in beakers of crushed ice, and managers of local tyre garages calibrate wheelbalancing instruments weekly. Organisation of a recalibration schedule should be within the capacity of any practice.
Clinical and ethical implications
Clinicians who use an uncalibrated sphygmomanometer will classify some young women as hypertensive. We have demonstrated that virtually all of these young women will have been misclassified. The first duty of a doctor is to do no harm: nonmaleficence. Unfortunately, since all drugs have potential side effects and all treatments inconvenience patients, preventive treatments in healthy patients may break this injunction. This is ethical when it is judged that the likelihood of the patient benefiting from treatment exceeds the likelihood of the treatment causing harm. That is, when a benefitrisk threshold-such as that specified in the British Hypertension Guidelines-is exceeded. 8 There may be specific reasons to measure a young (under 35) woman's blood pressure, such as pregnancy or renal disease. However, if blood pressure estimation is carried out with the aim of preventing cardiovascular disease the results clearly show that unselected young women are much more likely to be misclassified than correctly identified as hypertensive. Since a misclassified young woman is clearly below the benefit-risk threshold: treating her would break the injunction to do no harm. Checking her blood pressure with an uncalibrated instrument can only result in harm, it therefore cannot be ethical.
Public health implications
There are about 7 million women aged from 16 to 34 in England and Wales. The great majority have their blood pressure checked frequently: for example following registration with a practice or when receiving contraceptive advice. Our model suggests that about 7000 (0.1%) are at risk of misclassification and inappropriate treatment as a result of sphygmomanometer calibration error. In England and Wales about 24 000 women under 35 are on hypotensive treatment. 15 We do not know how many of these women are receiving treatment unnecessarily.
Legal implications
In a non-clinical situation a professional practitioner has clear legal responsibilities. For example, a professional surveyor may take a series of measurements to determine whether a house shows signs of subsidence. He may advise expensive restorative work on the basis of his measurements. What if the owner later finds out that the surveyor's instruments were not calibrated; that the relevant professional body recommends annual recalibration; and that because of this lack of calibration the advice is very likely to have been inappropriate? The professional surveyor has failed in his duty of care, he is at fault and is liable for any costs incurred by the owner. The clinical situation is clearly equivalent. Would the legal interpretation be the same? To date this has not been tested.
Conclusions
Calibration of sphygmomanometers is within the scope of all general practices. Primary care practitioners have a clinical, ethical and possibly legal responsibility to ensure their instruments are appropriately serviced and maintained. As a minimum first step, all clinicians should have a system in place to ensure that their sphygmomanometers are recalibrated regularly to the standard endorsed by the British Hypertension Society. Any clinician who does not have such a system is in place, should stop measuring blood pressure in healthy young women.
